Vivek Jain, CEO & Chairman of ICU Medical, purchased company shares on September 4, 2025.
4 reports, 3 independent
Updated Aug 6
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vivek Jain, CEO & Chairman of ICU Medical, purchased company shares on September 4, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ICU Medical
California-based company that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications
-
Vivek Jain
researcher (ORCID 0000-0002-1650-5527)
Coverage
Newest first; wire copies grouped- Simply Wall St.Insider Stock Buying Reaches US$2.63m On ICU Medical In the last year, multiple insiders have substantially increased their holdings of ICU Medical, Inc. (NASDAQ:ICUI) stock, indicating that insiders
- StockStoryICU Medical’s (NASDAQ:ICUI) Q2: Beats On Revenue Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2025 results exceeding the market’s revenue expectations , but sales fell by 8% year on
- GlobeNewswireICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance SAN CLEMENTE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the de